NewGenIvf (NIVF) CFO Chan Chung Ho files initial insider Form 3

Rhea-AI Filing Summary

NewGenIvf Group Ltd Chief Financial Officer Chan Chung Ho has filed an initial insider ownership report on Form 3 for the company’s ordinary shares. The filing lists him as an officer with the title Chief Financial Officer and does not report any insider transactions in the available data.

Understanding Insider Trading Forms →

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Chan Chung Ho

(Last) (First) (Middle)

C/O 1/F, PIER 2, CENTRAL

(Street)

HONG KONG 00000

(City) (State) (Zip)

HONG KONG

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
NewGenIvf Group Ltd [ NIVF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

This Form 3 is being filed after the March 18, 2026 deadline due to delay in issuance of EDGAR access codes following timely submission of the Form ID application on March 10, 2026. The filing is made promptly upon receipt of the access codes.

No securities are beneficially owned.

	/s/ Ho Fai Chung	03/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

FAQ

What does the NewGenIvf (NIVF) Form 3 filing by Chan Chung Ho show?

The Form 3 shows that Chan Chung Ho is an officer of NewGenIvf Group Ltd with the title Chief Financial Officer. The available data does not indicate any insider buy, sell, or other transaction activity in this initial ownership report.

Is the NewGenIvf (NIVF) Form 3 filing by the CFO a buy or sell signal?

The Form 3 for NewGenIvf Group Ltd reports no buys, sells, or other insider transactions in the summarized data. It serves as an initial ownership registration for Chief Financial Officer Chan Chung Ho, rather than a trading or directional signal for the stock.

What role does Chan Chung Ho have at NewGenIvf (NIVF) in this Form 3?

The filing identifies Chan Chung Ho as an officer of NewGenIvf Group Ltd with the title Chief Financial Officer. This establishes him as a reporting person subject to insider disclosure rules, even though no specific transactions are listed in the summary provided.

Does the NewGenIvf (NIVF) Form 3 include any derivative or option positions?

The derivative section in the summarized Form 3 data for NewGenIvf Group Ltd is empty. There are no reported option, warrant, or other derivative holdings or exercises associated with Chief Financial Officer Chan Chung Ho in this particular initial ownership report.

Why is NewGenIvf (NIVF) filing a Form 3 for its Chief Financial Officer?

Form 3 establishes initial insider ownership when someone becomes a reporting person like an officer or director. For NewGenIvf Group Ltd, Chief Financial Officer Chan Chung Ho is now formally listed as a reporting person, even though no transactions appear in the summarized data.